Sotrovimab, the anti-viral medicine for COVID-19, is 100 per cent effective in preventing death, according to the latest study results released by MoHAP.
It showed that 97 per cent of the recipients recovered within 14 days and prevented ICU admission in 99 per cent of the cases.
The study was carried out between June 30 and July 13 in collaboration with the Abu Dhabi Department of Health and Dubai Health Authority (DHA).
Over 6,100 patients were given the anti-viral medicine, of which 52 per cent were aged 50 or above and had multiple pre-existing medical conditions.
The UAE was one of the first countries to receive the shipment of the medicine and had approved its use in June.


UAE air defences intercept 5 missiles, 17 drones on Tuesday
UAE carries out over 8,000 inspections across markets to protect consumers
UAE condemns Iranian attacks on Bahrain
UAE President and NATO Secretary General discuss regional developments
UAE, Slovenia condemn Iran attacks and regional developments
UAE hosts the operation to release an American citizen from Afghanistan
Sheikh Abdullah expresses solidarity with Turkey over helicopter crash
UAE, Malaysia discuss regional developments and security
UAE carries out over 80 inspections in March to check medicine stockpile
Sharjah extends free parking until further notice
UAE warns drivers of strict fines for unsafe driving in rainy weather
UAE President meets with France's Armed Forces Minister in Abu Dhabi
UAE air defences intercept 7 missiles, 16 drones on Monday
UAE condemns the targeting of a hospital in Sudan's Darfur
Abdullah bin Zayed discusses latest developments with foreign ministers
Scholarship applications opens for 'exceptional' Emirati students
UAE and Indonesian Presidents discuss regional developments
UAE issues safety guidelines, travel advisories due to unstable weather
UAE stands with Canada, US over Air Canada Express crash
Sharjah temporarily closes public parks due to unstable weather
